HealthTimes

Health News

WHO Suspends Supply Of Indian Vaccine, Covaxin

Michael Gwarisa

THE World Health Organisation (WHO), has with immediate effect, suspended the supply of the Indian manufactured COVAXIN shots following the outcome of an inspection in March 2022, where deficiencies and manufacturing related concerns were identified. By Michael Gwarisa The decision by WHO has also prompted Bharat Biotech, the manufacturer to immediately suspend production of Covaxin,

Read More
Health News

Restart Whole Vaccination Process, COVAXIN Recipients Told

Michael Gwarisa

THE COVID-19 Chief Coordinator in the President’s Office, Dr Agness Mahomva has urged Zimbabweans who received their first jabs of COVAXIN vaccine but failed to get their second doses to start afresh with a different one. By Patricia Mashiri She made this plea following indications that thousands of people who received their first doses of

Read More
Features

Exclusive!!! MCAZ Speaks On COVID-19 Vaccines Linked Reactions In Zim

Michael Gwarisa

ZIMBABWE commenced its national vaccination initiative in February, 2021, kickstarting a campaign that would later yield positive results in the country’s COVID-19 management matrix. Even though only 14% of the national population has been vaccinated to date, available Ministry of Health and Child Care (MoHCC) data shows that vaccination has been working in minimizing the

Read More
Health News

COVAXIN Jab Recipients Haven’t Received Second Dose Five Months Down The Line

Michael Gwarisa

GETTING the second dose of the COVAXIN vaccine is proving to be a mammoth task for thousands of Zimbabweans who received the first dose of Indian manufactured vaccine with evidence on the ground showing that majority who received their jabs in May haven’t received their second shots to date, HealthTimes has learnt. By Michael Gwarisa

Read More
UN070241
Health News

Sinopharm Suits Zimbabwe’s Cold Chain Capacity

Michael Gwarisa

UNLIKE other COVID-19 vaccines that were developed using  the Messenger Ribonucleic Acids (M-RNA) technology, vaccines manufactured using a killed/inactivated virus such as the Sinopharm, Sinovac and COVAXIN currently being administered in Zimbabwe do not require expensive subzero cold-chain infrastructure. By Michael Gwarisa The messenger RNA technology was deployed in the Pfizer, Mordena and other vaccines,

Read More
Dr Grant Murewanhema
Health News

Zim COVID-19 Epidemic Curve Flattening – Dr Grant

Michael Gwarisa

LOCAL Public Health Expert and Epidemiologist, Dr Grant Murewanhema has hinted that Zimbabwe’s epidemic curve was at the verge of flattening even though clustered sections of infections were still reported at community level. By Michael Gwarisa An epidemic curve, also known as an epi curve or epidemiological curve, is a statistical chart used to visualize

Read More